Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone for Psychotic Symptoms in Major Depressive Disorder
NCT00637494Phase 3Terminated
- Sponsor
- Corcept Therapeutics
- Start
- Mar 2008
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of mifepristone, sponsored by Corcept Therapeutics. Started Mar 2008; status: terminated.
02
Drugs
mifepristone
Beyond the preview
Go deeper on NCT00637494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637494.